Why the study?
The predictive performance of universal early warning scores (EWS) across specific disease subgroups and clinical settings remained to be systematically evaluated.
Do universal early warning scores accurately predict clinical deterioration in different patient subgroups and clinical settings?
Do universal early warning scores accurately predict clinical deterioration in different patient subgroups and clinical settings?
The methodology and quality of validation studies for early warning scores are currently insufficient to recommend their universal use across all diseases and clinical settings.
No takes yet. Share an insight, caveat, or question.
Apply universal EWS cautiously outside well-studied medical/surgical settings; leaves open high-quality CVD-specific validation given sparse data.
Alhmoud et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: